Revenue Breakdown
Composition ()
No data
Revenue Streams
DENTSPLY SIRONA Inc (XRAY) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Implants & Prosthetics, accounting for 16.8% of total sales, equivalent to $152.00M. Other significant revenue streams include Equipment & Instruments and CAD/CAM. Understanding this composition is critical for investors evaluating how XRAY navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, DENTSPLY SIRONA Inc maintains a gross margin of 48.78%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 5.42%, while the net margin is -47.35%. These profitability ratios, combined with a Return on Equity (ROE) of -44.44%, provide a clear picture of how effectively XRAY converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, XRAY competes directly with industry leaders such as ATEC and INSP. With a market capitalization of $2.42B, it holds a leading position in the sector. When comparing efficiency, XRAY's gross margin of 48.78% stands against ATEC's 67.97% and INSP's 85.85%. Such benchmarking helps identify whether DENTSPLY SIRONA Inc is trading at a premium or discount relative to its financial performance.
